Achievements

Home
Achievements

Collab. with Gov't/Academia

Tetsuomi Takano has been appointed a…

2025.12.10

Collab. with Gov't/Academia

November 14, 2025: Japan Session Suc…

2025.11.14

Conferences

Activities of “Drug R&D E…

2025.10.30

Collaboration with Industry

We held the 32nd Red Dragon Conferen…

2025.09.12

Collab. with Gov't/Academia

The Japan-China Session was successf…

2025.05.24

Conferences

Keynote Lecture at China-Japan Sessi…

2025.05.24

Collaboration with Industry

We held the 31st Red Dragon Conferen…

2024.12.6

Conferences

We co-held a Japan Promotion Session…

2024.11.12

Collaboration with Industry

We held the 30th Red Dragon Conferen…

2024.08.30

Conferences

Presented at Japan Session (Organize…

2024.08.9

Collab. with Gov't/Academia

Collaboration with PMDA and JPMA at …

2024.05.18

Conferences

t2T Healthcare discussed with regula…

2024.05.17

Collab. with Gov't/Academia

Collaboration with Dalian University…

2024.02.27

Corporate

Trademarks of t2T Healthcare Inc. we…

2024.02.22

Collaboration with Industry

We held the 29th Red Dragon Conferen…

2023.12.1

About t2T Healthcare Inc.

Message from the CEO

Achievements

Tetsuomi Takano has been appointed a…

November 14, 2025: Japan Session Suc…

Activities of “Drug R&D E…

We held the 32nd Red Dragon Conferen…

The Japan-China Session was successf…

Keynote Lecture at China-Japan Sessi…

We held the 31st Red Dragon Conferen…

We co-held a Japan Promotion Session…

We held the 30th Red Dragon Conferen…

Presented at Japan Session (Organize…

Collaboration with PMDA and JPMA at …

t2T Healthcare discussed with regula…

Collaboration with Dalian University…

Trademarks of t2T Healthcare Inc. we…

We held the 29th Red Dragon Conferen…

Latest News

Category

Archive